<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement">
 <title>Conflicts of Interest</title>
 <p>The research described in this paper was sponsored by Bencard Adjuvant Systems, Dominion Way, Worthing, BN14 8SA, UK. MD Heath, Matthias F. Kramer and Murray A. Skinner are all employees of Allergy Therapeutics plc. Martin F. Bachmann started and owns shares of several companies involved in the development of CuMVtt-based vaccines. The other authors have no other relevant affiliations or financial involvement with any other organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. </p>
</notes>
